Skip to main content
Figure 5 | Critical Care

Figure 5

From: Bench-to-bedside review: Vasopressin in the management of septic shock

Figure 5

Doses of norepinephrine infusions in the Vasopressin and Septic Shock Trial. Rates of total norepinephrine infusion (open-label and study drug) in the Vasopressin and Septic Shock Trial for the vasopressin-treated group (black squares) and for the norepinephrine-treated group (grey circles) amongst all patients who were treated with open-label norepinephrine at baseline. The rates of norepinephrine infusion were significantly lower in the vasopressin group than in the norepinephrine group over the first 4 days (P < 0.001). Values are median and interquartile range (IQR).

Back to article page